Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Equity Average (2016 - 2026)

Biomerica's Equity Average history spans 16 years, with the latest figure at $3.9 million for Q1 2026.

  • Quarterly results put Equity Average at $3.9 million for Q1 2026, down 27.2% from a year ago — trailing twelve months through Feb 2026 was $3.9 million (down 27.2% YoY), and the annual figure for FY2025 was $5.3 million, down 41.6%.
  • Equity Average for Q1 2026 was $3.9 million at Biomerica, down from $4.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $11.2 million in Q3 2023 to a low of $3.9 million in Q1 2026.
  • The 5-year median for Equity Average is $7.2 million (2024), against an average of $7.2 million.
  • The sharpest move saw Equity Average surged 35.11% in 2023, then plummeted 48.09% in 2024.
  • Year by year, Equity Average stood at $7.8 million in 2022, then increased by 29.46% to $10.1 million in 2023, then plummeted by 48.09% to $5.2 million in 2024, then dropped by 8.32% to $4.8 million in 2025, then fell by 19.17% to $3.9 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods came in at $3.9 million, $4.8 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.